Classical Hodgkin Lymphoma Latest Advances

Targeted therapy in early-stage classical Hodgkin lymphoma.

Journal: Blood

Published: April 09, 2026

Primary Classical Hodgkin Lymphoma of the Urinary Bladder: Expanding the Spectrum of Bladder Lymphoid Neoplasms.

Journal: International journal of surgical pathology

Published: April 01, 2026

The predictive and prognostic role of baseline 2-[18F]FDG PET/CT volumetric and dissemination features in classical Hodgkin lymphoma.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 21, 2026

Mind the gap: anti-PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma.

Journal: Haematologica

Published: February 19, 2026

Liu X, Zhang Q, Guo H, Pan Q, Zhou K. Bendamustine, gemcitabine, and vinorelbine (BeGEV) regimen followed by ASCT induces durable remissions in PD-(L)1 inhibitor-resistant refractory/relapsed classical Hodgkin lymphoma: a single-center, long-term study. Blood. 2025;146(suppl 1):1847.

Journal: Blood

Published: February 05, 2026

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.

Journal: Annals of hematology

Published: February 03, 2026

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 13, 2025

Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive Biomarkers.

Journal: EJHaem

Published: December 12, 2025

American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.

Journal: Transplantation and cellular therapy

Published: December 09, 2025

Expression of sialylated CD15 in classical Hodgkin lymphoma following sialidase digestion

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: December 08, 2025

Rare Case of Metastasis of Classical Hodgkin Lymphoma to the Eye.

Journal: Pediatric blood & cancer

Published: December 07, 2025

Adriamycin, Vinblastine and Dacarbazine With Immunotherapy Achieves Complete Metabolic Response in a Patient With Classical Hodgkin Lymphoma and Dyskeratosis Congenita.

Journal: Journal of hematology

Published: November 25, 2025

Classical Hodgkin Lymphoma Latest Advances

Find the Latest Research About Classical Hodgkin Lymphoma

Targeted therapy in early-stage classical Hodgkin lymphoma.

Targeted therapy in early-stage classical Hodgkin lymphoma.

Primary Classical Hodgkin Lymphoma of the Urinary Bladder: Expanding the Spectrum of Bladder Lymphoid Neoplasms.

Primary Classical Hodgkin Lymphoma of the Urinary Bladder: Expanding the Spectrum of Bladder Lymphoid Neoplasms.

The predictive and prognostic role of baseline 2-[18F]FDG PET/CT volumetric and dissemination features in classical Hodgkin lymphoma.

The predictive and prognostic role of baseline 2-[18F]FDG PET/CT volumetric and dissemination features in classical Hodgkin lymphoma.

Mind the gap: anti-PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma.

Mind the gap: anti-PD-1 salvage before autologous transplantation in classical Hodgkin lymphoma.

Liu X, Zhang Q, Guo H, Pan Q, Zhou K. Bendamustine, gemcitabine, and vinorelbine (BeGEV) regimen followed by ASCT induces durable remissions in PD-(L)1 inhibitor-resistant refractory/relapsed classical Hodgkin lymphoma: a single-center, long-term study. Blood. 2025;146(suppl 1):1847.

Liu X, Zhang Q, Guo H, Pan Q, Zhou K. Bendamustine, gemcitabine, and vinorelbine (BeGEV) regimen followed by ASCT induces durable remissions in PD-(L)1 inhibitor-resistant refractory/relapsed classical Hodgkin lymphoma: a single-center, long-term study. Blood. 2025;146(suppl 1):1847.

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.

Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients.

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.

Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma.

Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive Biomarkers.

Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive Biomarkers.

American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.

American Society of Transplantation and Cellular Therapy Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma.

Expression of sialylated CD15 in classical Hodgkin lymphoma following sialidase digestion

Expression of sialylated CD15 in classical Hodgkin lymphoma following sialidase digestion

Rare Case of Metastasis of Classical Hodgkin Lymphoma to the Eye.

Rare Case of Metastasis of Classical Hodgkin Lymphoma to the Eye.

Adriamycin, Vinblastine and Dacarbazine With Immunotherapy Achieves Complete Metabolic Response in a Patient With Classical Hodgkin Lymphoma and Dyskeratosis Congenita.

Adriamycin, Vinblastine and Dacarbazine With Immunotherapy Achieves Complete Metabolic Response in a Patient With Classical Hodgkin Lymphoma and Dyskeratosis Congenita.